A new light-based technique for measuring levels of the toxic protein that causes Huntington's disease (HD) has been used to demonstrate that the protein builds up gradually in blood cells.
Contrary to previous findings, new research finds no link between chronic fatigue syndrome and the viruses XMRV (xenotropic murine leukemia virus-related virus) and pMLV (polytropic murine leukemia virus). A study reveals that research that reported patients with chronic fatigue syndrome carried these two viruses was wrong and that there is still no evidence for an infectious cause behind chronic fatigue syndrome.
According to a new study, men with high levels of urate in their blood have a lower risk of developing Parkinson's disease.
A new blood test can accurately predict whether a person will respond to common antidepressants.
Researchers have developed a new blood test that could help to identify infants who may be experiencing bleeding in the brain as a result of abusive head trauma.
A simple blood test may help to reveal a person's risk of developing multiple sclerosis, According to a new study, low levels of vitamin D in the blood is linked to a higher risk of developing MS, especially in young and middle aged women.
Researchers have developed new tests that could help lead to earlier diagnosis of autism.
Researchers have developed a new algorithm that uses data based on metabolites in blood samples to successfully predict if a child is on the autism spectrum.
Researchers have identified two new species of bacteria in the blood of patients in China. The bacterias are in the Enterobacter genus and are resistant to multiple antibiotics. Enterobacter has previously been linked to meningitis and other serious medical conditions.
Novel biomarkers for glioblastoma brain cancer have been identified in bodily fluids. The discovery may lead to a new, simple, non-invasive blood test to detect brain cancer in the future.
··3 min read
Combining artificial intelligence technology and blood samples, researchers were able to predict and explain the progression of Alzheimer's and Huntington's disease. The new algorithm was able to detect alterations in gene expression over decades from patients' blood samples.
Six proteins in the blood can be used to assess a person's risk of developing cerebral small vessel disease (CSVD). CSVD has been linked to an increased risk of stroke and Alzheimer's disease.
